Obesity and Semaglutide: Benefits and Risks
Year: 2025
Type: article
Abstract: Obesity is a widespread health issue that places a significant burden on healthcare systems around the world. It is also associated with an increased risk of developing chronic conditions such as type 2 diabetes, cardiovascular disease, hypertension, and certain types of cancer. This condition, defined by the WHO as an excessive accumulation of body fat that impairs health, results from a combination of genetic, environmental, behavioral, and metabolic factors. The growing prevalence of obesity, along with the aging global population, has driven the medical and scientific communities to develop treatments that not only support weight loss but also address the underlying metabolic mechanisms. In this context, semaglutide has emerged as a promising medication for managing obesity. It is seen as a tool to enhance the effectiveness of non-pharmacological strategies, such as lifestyle changes, balanced nutrition, and physical activity. However, its popularity on social media—often driven by celebrity endorsements for cosmetic purposes—has raised concerns among health authorities about the potential misuse of the drug. It is therefore important to review what semaglutide is, along with its benefits and risks. The following is a summary of this information.
Authors: Centro de Información de Medicamentos de la Universidad Nacional, Aponte-Gonzalez, Johanna, Perez Perdomo, Johann Esteban, Zona, Diana Carolina
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6949415897
FWCI:
Cites:
Cited by:
Related to: